Skip to main content
Type at least 3 characters

226 articles

Original Research

Published on 15 Dec 2023

Risk factors for coronary artery abnormalities and resistance to immunoglobulin plus ciclosporin A therapy in severe Kawasaki disease: subanalysis of the KAICA trial, randomized trial for cicrosporin A as the first-line treatment

in Pediatric Rheumatology

  • Yuri Murayama
  • Hiromichi Hamada
  • Yuki Shiko
  • Yoshihiro Onouchi
  • Nobuyuki Kakimoto
  • Yoshihito Ozawa
  • Hideki Hanaoka
  • Akira Hata
  • Hiroyuki Suzuki
Frontiers in Pediatrics
doi 10.3389/fped.2023.1321533
  • 1,894 views
  • 2 citations